Pregnancy and liver disease
- Grace L. Su
- … show all 1 hide
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Although liver disease does not occur frequently during pregnancy, when it does, it can cause significant morbidity and mortality for both fetus and mother. Recent advances in molecular genetics have provided some insight into the pathogenesis of diseases such as intrahepatic cholestasis of pregnancy (IHCP) and acute fatty liver of pregnancy. Newer studies linking serum bile acid levels with fetal outcome support the importance of this marker in IHCP. Randomized trials with ursodeoxycholic acid have shown promising results in reducing maternal symptoms and serum bile acid levels in IHCP. Although further studies must be performed, early strategies aimed at reducing viral loads in mothers may reduce perinatal transmission of hepatitis B.
- Dodds L, Fell DB, Joseph KS, et al.: Outcomes of pregnancies complicated by hyperemesis gravidarum. Obstet Gynecol 2006, 107:285–292.
- Lee RH, Goodwin TM, Greenspoon J, et al.: The prevalence of intrahepatic cholestasis of pregnancy in a primarily Latina Los Angeles population. J Perinatol 2006, 26:527–532. CrossRef
- Schneider G, Paus TC, Kullak-Ublick GA, et al.: Linkage between a new splicing site mutation in the MDR3 alias ABCB4 gene and intrahepatic cholestasis of pregnancy. Hepatology 2007, 45:150–158. CrossRef
- Floreani A, Carderi I, Paternoster D, et al.: Intrahepatic cholestasis of pregnancy: three novel MDR3 gene mutations. Aliment Pharmacol Ther 2006, 23:1649–1653. CrossRef
- Poupon R: Intrahepatic cholestasis of pregnancy: from bedside to bench to bedside. Liver Int 2005, 25:467–468. CrossRef
- Beuers U, Pusl T: Intrahepatic cholestasis of pregnancy-a heterogeneous group of pregnancy-related disorders? Hepatology 2006, 43:647–649. CrossRef
- Reyes H, Zapata R, Hernandez I, et al.: Is a leaky gut involved in the pathogenesis of intrahepatic cholestasis of pregnancy? Hepatology 2006, 43:715–722. CrossRef
- Glantz A, Marschall HU, Mattsson LA: Intrahepatic cholestasis of pregnancy: relationships between bile acid levels and fetal complication rates. Hepatology 2004, 40:467–474. CrossRef
- Binder T, Salaj P, Zima T, et al.: Randomized prospective comparative study of ursodeoxycholic acid and S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis of pregnancy. J Perinat Med 2006, 34:383–391. CrossRef
- Glantz A, Marschall HU, Lammert F, et al.: Intrahepatic cholestasis of pregnancy: a randomized controlled trial comparing dexamethasone and ursodeoxycholic acid. Hepatology 2005, 42:1399–1405. CrossRef
- Sentilhes L, Verspyck E, Roman H, et al.: Intrahepatic cholestasis of pregnancy and bile acid levels. Hepatology 2005, 42:737–738; author reply 738. CrossRef
- Sentilhes L, Verspyck E, Pia P, et al.: Fetal death in a patient with intrahepatic cholestasis of pregnancy. Obstet Gynecol 2006, 107:458–460.
- Alsulyman OM, Ouzounian JG, Ames-Castro M, et al.: Intrahepatic cholestasis of pregnancy: perinatal outcome associated with expectant management. Am J Obstet Gynecol 1996, 175:957–960. CrossRef
- Kondrackiene J, Beuers U, Kupcinskas L: Efficacy and safety of ursodeoxycholic acid versus cholestyramine in intrahepatic cholestasis of pregnancy. Gastroenterology 2005, 129:894–901. CrossRef
- Weinstein L: Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol 1982, 142:159–167.
- Sibai BM, Ramadan MK, Usta I, et al.: Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol 1993, 169:1000–1006.
- Guntupalli SR, Steingrub J: Hepatic disease and pregnancy: an overview of diagnosis and management. Crit Care Med 2005, 33:S332–S339. CrossRef
- Martin JN, Jr, Rose CH, Briery CM: Understanding and managing HELLP syndrome: the integral role of aggressive glucocorticoids for mother and child. Am J Obstet Gynecol 2006, 195:914–934. CrossRef
- Sibai BM, Taslimi MM, el-Nazer A, et al.: Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia. Am J Obstet Gynecol 1986, 155:501–509.
- O’Brien JM, Barton JR: Controversies with the diagnosis and management of HELLP syndrome. Clin Obstet Gynecol 2005, 48:460–477. CrossRef
- Martin JN, Jr, Rinehart BK, May WL, et al.: The spectrum of severe preeclampsia: comparative analysis by HELLP (hemolysis, elevated liver enzyme levels, and low platelet count) syndrome classification. Am J Obstet Gynecol 1999, 180:1373–1384. CrossRef
- Magann EF, Bass D, Chauhan SP, et al.: Antepartum corticosteroids: disease stabilization in patients with the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP). Am J Obstet Gynecol 1994, 171:1148–1153.
- Magann EF, Perry KG, Jr, Meydrech EF, et al.: Postpartum corticosteroids: accelerated recovery from the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP). Am J Obstet Gynecol 1994, 171:1154–1158.
- Isler CM, Barrilleaux PS, Magann EF, et al.: A prospective, randomized trial comparing the efficacy of dexamethasone and betamethasone for the treatment of antepartum HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome. Am J Obstet Gynecol 2001, 184:1332–1337, discussion 1337–1339. CrossRef
- Tompkins MJ, Thiagarajah S: HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome: the benefit of corticosteroids. Am J Obstet Gynecol 1999, 181:304–309. CrossRef
- Martin JN, Jr, Files JC, Blake PG, et al.: Postpartum plasma exchange for atypical preeclampsia-eclampsia as HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol 1995, 172:1107–1125, discussion 1125–1127. CrossRef
- Martin JN, Jr, Perry KG, Jr, Roberts WE, et al.: Plasma exchange for preeclampsia: III. Immediate peripartal utilization for selected patients with HELLP syndrome. J Clin Apher 1994, 9:162–165. CrossRef
- Smith LG, Jr, Moise KJ, Jr, Dildy GA III, et al.: Spontaneous rupture of liver during pregnancy: current therapy. Obstet Gynecol 1991, 77:171–175. CrossRef
- Ibdah JA, Bennett MJ, Rinaldo P, et al.: A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women. N Engl J Med 1999, 340:1723–1731. CrossRef
- Ibdah JA: Acute fatty liver of pregnancy: an update on pathogenesis and clinical implications. World J Gastroenterol 2006, 12:7397–7404.
- Browning MF, Levy HL, Wilkins-Haug LE, et al.: Fetal fatty acid oxidation defects and maternal liver disease in pregnancy. Obstet Gynecol 2006, 107:115–120.
- Chang MH: Hepatitis B virus infection. Semin Fetal Neonatal Med 2007, 12:160–167. CrossRef
- Ngui SL, Andrews NJ, Underhill GS, et al.: Failed postnatal immunoprophylaxis for hepatitis B: characteristics of maternal hepatitis B virus as risk factors. Clin Infect Dis 1998, 27:100–106. CrossRef
- del Canho R, Grosheide PM, Mazel JA, et al.: Ten-year neonatal hepatitis B vaccination program, The Netherlands, 1982–1992: protective efficacy and long-term immunogenicity. Vaccine 1997, 15:1624–1630. CrossRef
- van Zonneveld M, van Nunen AB, Niesters HG, et al.: Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection. J Viral Hepat 2003, 10:294–297. CrossRef
- Su GG, Pan KH, Zhao NF, et al.: Efficacy and safety of lamivudine treatment for chronic hepatitis B in pregnancy. World J Gastroenterol 2004, 10:910–912.
- Xu WM, Cui YT, Wang L, et al.: Efficacy and safety of lamivudine in late pregnancy for the prevention of mother-child transmission of hepatitis B: a multicentre, randomised, double blind, placebo-controlled study [abstract 246]. Hepatology 2004, 40:272A.
- Xiao XM, Li AZ, Chen X, et al.: Prevention of vertical hepatitis B transmission by hepatitis B immunoglobulin in the third trimester of pregnancy. Int J Gynaecol Obstet 2007, 96:167–170. CrossRef
- Pregnancy and liver disease
Current Gastroenterology Reports
Volume 10, Issue 1 , pp 15-21
- Cover Date
- Print ISSN
- Online ISSN
- Current Science Inc.
- Additional Links
- Grace L. Su (1)
- Author Affiliations
- 1. Ann Arbor Veterans Administration Health Center, University of Michigan Medical School, Gastroenterology Section 111D, 2215 Fuller Road, Ann Arbor, MI, 48105, USA